Advertisement

Topics

Congenica Company Profile

10:45 EDT 18th June 2019 | BioPortfolio

Congenica, a leading provider of genomic analysis software and services, has developed the gold-standard clinical genomics analysis platform Sapientia™. Based in Cambridge, UK, and born out of pioneering research from the Sanger Institute, Congenica aims to revolutionize personalized patient care through accurate diagnoses, curation of evolving knowledge bases and support in clinical trials and drug development.


News Articles [9 Associated News Articles listed on BioPortfolio]

Digital China Participates in $17 Million Funding for UK's Congenica

Digital China Health Technologies participated in a $17.1 million extension of a Congenica Series B funding that has now raised a total of $30 million. Congenica, a UK company, is developing the next ...

Congenica raises £8mm in Series B round; closes round at £23.3mm

Congenica Ltd. (whole genome analysis) raised £8mm ($10mm) through its Series B round from existing investors Cambridge Innovation Capital and Amadeus Capital partners, who were joined by first-time ...

Congenica co-founder and Scientific Director Dr Matthew Hurles Elected to Fellowship of the Royal Society

Cambridge, United Kingdom – 18 April, 2019 - Congenica, the global diagnostic decision support platform provider, congratulates its co-founder and Scientific Director, Dr Matthew Hurles, FMedS...

Congenica Announces On-Premise Deployment Option for its SapientiaTM Platform.

Cambridge, United Kingdom - 1 April, 2019 - Congenica, the global diagnostic decision support platform provider, has announced that it now offers an on-premise deployment method in addition to cloud...

Congenica Announces On-Premise Deployment Option for its Sapientia (TM) Platform.

Cambridge, United Kingdom - 1 April, 2019 - Congenica, the global diagnostic decision support platform provider, has announced that it now offers an on-premise deployment method in addition to c...

Congenica Announces On-Premise Deployment Option for its SapientiaTM Platform

Congenica, the global diagnostic decision support platform provider, has announced that it now offers an on-premise deployment method in addition to cloud deployment for ru...

Congenica raises £23.3m in series B funding round

The company was recently awarded a multi-year contract to be the exclusive provider of Diagnostic Decision Support Services for the world leading NHS Genomic Medicine Service

Congenica Raises Additional £13.25M ($17.1M) to Reach Total of £23.3M ($30.1M) for Series B Funding Round

Extension of Series B investment round, led by existing investor Parkwalk Advisors Digital China Health joins as new investor, building on existing ...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Congenica

Congenica, a leading provider of genomic analysis software and services, has developed the gold-standard clinical genomics analysis platform Sapientia™. Based in Cambridge, U...

More Information about "Congenica" on BioPortfolio

We have published hundreds of Congenica news stories on BioPortfolio along with dozens of Congenica Clinical Trials and PubMed Articles about Congenica for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Congenica Companies in our database. You can also find out about relevant Congenica Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record